Neurobiology of opioid dependence in creating addiction vulnerability.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27508068)

Published in F1000Res on July 19, 2016

Authors

Christopher J Evans1, Catherine M Cahill2

Author Affiliations

1: Hatos Center for Neuropharmacology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA, 90095, USA.
2: Departments of Anesthesiology & Perioperative Care and Pharmacology, University of California, Irvine, CA, 90095, USA; Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, K7L 3N6, Canada.

Articles cited by this

Neurocircuitry of addiction. Neuropsychopharmacology (2010) 14.22

Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A (2015) 9.32

Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev (2004) 9.30

Addiction and the brain antireward system. Annu Rev Psychol (2008) 5.17

Incentive-sensitization and addiction. Addiction (2001) 4.90

Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci (2008) 4.60

Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci (2005) 4.36

A multistep general theory of transition to addiction. Psychopharmacology (Berl) (2013) 4.01

The brain disease model of addiction: is it supported by the evidence and has it delivered on its promises? Lancet Psychiatry (2015) 3.24

Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin. JAMA Psychiatry (2015) 3.18

Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies. N Engl J Med (2016) 3.15

Reward-guided learning beyond dopamine in the nucleus accumbens: the integrative functions of cortico-basal ganglia networks. Eur J Neurosci (2008) 3.07

Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch Gen Psychiatry (2009) 2.95

Vietnam veterans three years after Vietnam: how our study changed our view of heroin. Am J Addict (2010) 2.72

Reward processing by the opioid system in the brain. Physiol Rev (2009) 2.46

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev (2013) 2.42

Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis. Nat Neurosci (2013) 2.37

Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment. Am J Psychiatry (2015) 2.20

The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berl) (2013) 2.01

Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse. Am J Psychiatry (1996) 1.87

The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health (2015) 1.86

Addiction as a stress surfeit disorder. Neuropharmacology (2013) 1.68

The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal. Ann N Y Acad Sci (1999) 1.60

Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun (2008) 1.58

Acute effects of heroin on negative emotional processing: relation of amygdala activity and stress-related responses. Biol Psychiatry (2013) 1.56

Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons. Eur J Neurosci (2000) 1.53

Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology (2004) 1.50

A thalamic input to the nucleus accumbens mediates opiate dependence. Nature (2016) 1.49

A temporal shift in the circuits mediating retrieval of fear memory. Nature (2015) 1.43

Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci (2008) 1.39

Buprenorphine treatment of refractory depression. J Clin Psychopharmacol (1995) 1.37

Pleasure systems in the brain. Neuron (2015) 1.34

Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med (2011) 1.28

The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci (2001) 1.25

A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder. Biol Psychiatry (2008) 1.22

Brain disease model of addiction: why is it so controversial? Lancet Psychiatry (2015) 1.21

Associative learning mechanisms underpinning the transition from recreational drug use to addiction. Ann N Y Acad Sci (2012) 1.20

Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress. Neuropsychopharmacology (2015) 1.17

Negative reinforcement in drug addiction: the darkness within. Curr Opin Neurobiol (2013) 1.15

The brain disease model of addiction: challenging or reinforcing stigma? Lancet Psychiatry (2015) 1.09

Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J Clin Psychiatry (2014) 1.08

Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug Alcohol Depend (2010) 1.07

Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology (2001) 1.06

Individual variation in the propensity to attribute incentive salience to an appetitive cue predicts the propensity to attribute motivational salience to an aversive cue. Behav Brain Res (2011) 1.05

The darkness within: individual differences in stress. Cerebrum (2015) 1.05

Effects of repeated cocaine exposure on habit learning and reversal by N-acetylcysteine. Neuropsychopharmacology (2014) 1.03

Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics. J Neurosci (2015) 1.03

Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal. Physiol Behav (2010) 1.01

"Should I stay or should I go?" Coming off methadone and buprenorphine treatment. Int J Drug Policy (2010) 0.99

Conditioning and opiate withdrawal. Nature (2000) 0.98

The role of learning-related dopamine signals in addiction vulnerability. Prog Brain Res (2014) 0.95

Abstinence fear in methadone maintenance withdrawal: a possible obstacle for getting off methadone. Subst Use Misuse (1997) 0.94

eIF2α dephosphorylation in basolateral amygdala mediates reconsolidation of drug memory. J Neurosci (2014) 0.93

Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PLoS One (2014) 0.92

Evaluation of opioid modulation in major depressive disorder. Neuropsychopharmacology (2014) 0.92

Contributions of the paraventricular thalamic nucleus in the regulation of stress, motivation, and mood. Front Behav Neurosci (2014) 0.91

Opiates as antidepressants. Curr Pharm Des (2009) 0.91

A potential role for the paraventricular nucleus of the thalamus in mediating individual variation in Pavlovian conditioned responses. Front Behav Neurosci (2014) 0.90

Losing ground at midlife in America. Proc Natl Acad Sci U S A (2015) 0.89

Chronic use of opioids and antipsychotic drugs: side effects, effects on endogenous opioids, and toxicity. Ann N Y Acad Sci (1982) 0.89

Neuroimmune Regulation of GABAergic Neurons Within the Ventral Tegmental Area During Withdrawal from Chronic Morphine. Neuropsychopharmacology (2015) 0.88

Prescription opioid abuse: Problems and responses. Prev Med (2015) 0.86

Placing the paraventricular nucleus of the thalamus within the brain circuits that control behavior. Neurosci Biobehav Rev (2015) 0.86

Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients. J Pain (2016) 0.85

Hypercortisolism after opioid discontinuation in rapid detoxification of heroin addicts. Br J Addict (1992) 0.85

Predictors of posttraumatic stress in children following injury: The influence of appraisals, heart rate, and morphine use. Behav Res Ther (2010) 0.85

Signals from the Fourth Dimension Regulate Drug Relapse. Trends Neurosci (2016) 0.84

The Origins and Organization of Vertebrate Pavlovian Conditioning. Cold Spring Harb Perspect Biol (2015) 0.83

Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia. Drug Alcohol Depend (2013) 0.83

Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies. Expert Opin Drug Discov (2014) 0.82

Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence. Neuropsychopharmacology (2014) 0.82

Sign-tracking to an appetitive cue predicts incubation of conditioned fear in rats. Behav Brain Res (2014) 0.82

Opiate-related dependence/abuse and PTSD exposure among the active-component U.S. military, 2001 to 2008. Mil Med (2014) 0.81

Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine. Eur J Neurosci (2015) 0.80

The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis. Pain Med (2014) 0.80

Minocycline Does Not Decrease Intensity of Neuropathic Pain Intensity, But Does Improve Its Affective Dimension. J Pain Palliat Care Pharmacother (2015) 0.80

Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy. J Subst Abuse Treat (2015) 0.79

Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction. Int Rev Neurobiol (2014) 0.79

A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats. Addict Biol (2014) 0.78

Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain. J Pain (2016) 0.78

Stress and opioids: role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference. Neurosci Biobehav Rev (2015) 0.77

Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample. Addict Behav (2016) 0.77

Corticostriatal circuitry in regulating diseases characterized by intrusive thinking. Dialogues Clin Neurosci (2016) 0.77

Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26weeks of withdrawal. Compr Psychiatry (2015) 0.76

Brain disease model of addiction: misplaced priorities? Lancet Psychiatry (2015) 0.76

Drug poisoning deaths in the United States, 1999-2012: a statistical adjustment analysis. Popul Health Metr (2016) 0.76